Allergan's Wide Moat Supports Industry-Leading Growth and Profit
Innovative products, strong IP, and an unmatched aesthetics franchise drive Allergan's growth outlook. We anticipate high-single-digit growth for...
389 Views
Gene Techno Science: Who? Yeah. But There Is Optionality Here. 2X.
Monday night after the close, small cap Noritsu Koki Co Ltd (7744 JP) announced a 3rd party equity injection and a subsequent tender offer for a...
458 Views
Stewardship Risk in Focus
Evidente developed a measure of firm complexity and agency costs, which was originally launched for Australian stocks in 2015, designed to provide...
522 Views
Biosensors: Docs Out Deal Really On
Bankers in Singapore are no doubt breathing a sigh of relief as the rumors of the SGX having finally approved the Amalgamation Document for the...
395 Views
Sharp: Interpretation Risk
Sharp now trades with Interpretation Risk. Two months ago, Hon Hai quite clearly tossed its hat into the ring as a potential savior of Sharp. As...
335 Views